Eesmyal Santos-Brault & Dr. Pamela Kryskow from Quantified Citizen talk about Quantified Citizen the app, and the results of Quantified Citizen's first study:  Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.   Check out the paper here:  https://www.nature.com/articles/s41598-021-01811-4 💰 Invest in Brom's Psychedelic VC Fund: https://www.empath.vc

The Integration Conversation is BACK with Nadia van der Heyden, Director of Sales and Marketing at Psygen.   Recorded at Wonderland Miami.      💰 Invest in Brom's Psychedelic VC Fund: https://www.empath.vc  🐦 brom on twitter:  https://twitter.com/therealbrom  💌 Email:   [email protected]

Brom discusses 10 interesting startup ideas for entrepreneurs in the psychedelics space.      The ideas include applications of psychedelics to non mental health disorders, sexual disfunction, anti-aging, digital addiction, crypto, non-5ht2a drugs, gender specific issues, sustainable manufacturing and digital therapeutics.     If you're an entrepreneur working on a psychedelic startup, we'd love to hear from you.  Please contact us at [email protected]    💰 Invest in Brom's Psychedelic VC Fund: https://www.empath.vc  📺 Watch on YouTube:  https://youtu.be/rpK8tzv2AaM

Mycrodose Therapeutics is a US-Based pharmaceutical company specializing in the development of Advanced Drug Delivery (ADD) systems for psychedelic compounds.  In this episode of The Integration Conversation, Mycrodose's Chad Conner and Patrick Eckstrom join Brom to discuss how ADD systems can potentially improve the patient experience, increase the safety profile and lower the cost of psychedelic drugs.     💰 Invest in Brom's Psychedelic VC Fund:  https://www.empath.vc   📺 Watch on YouTube: https://youtu.be/HmBsrUQYyOg  🐦 brom on twitter:   https://twitter.com/therealbrom  🎇 Clips and other stuff on Instagram:   https://instagram.com/theintegrationco  💌 Email:    [email protected]

Richard Skaife is a cofounder of The Conscious Fund, one of the leading Venture Capital funds focused on psychedelic medicine, which has invested in companies like Cybin and Numinus Wellness.  Richard has a very eclectic background which includes producing electronic music events and being trained in the art of hypnotism.   Richard shares his views on the psychedelics industry, talks about what it's like to run a psychedelic VC fund, and announces Wonderland:  Miami - an in person psychedelics industry conference this November!      ❤️ Invest in Brom's Psychedelic Venture Fund:  https://www.empath.vc

Todd Shapiro is the CEO of Red Light Holland ($TRIP, $TRUFF), the only publicly traded company focused on recreational psychedelics.    In this episode of The Integration Conversation, Todd explains the history of Red Light Holland, speculates on timelines for when Red Light Holland will be able to sell in the US, and tells us about Red Light Holland's foray into Virtual Reality and consumer products like the Wisdom Truffle.   And of course, we ask the big question:  Is Red Light Holland Undervalued?    --- ❤️ Invest in Brom's Psychedelic Venture Capital Fund:  https://www.empath.vc 📺Watch on YouTube: https://youtu.be/1OzpNIQDkyI   ⚠️Disclaimer:  This content is not financial advice. Brom holds shares in Red Light Holland

Negev Capital is a VC fund focused on psychedelic medicine.   In this episode of The Integration Conversation, Ken Belotsky and Stuart Seidman tell us about Negev's founding, its strategy, and what it's like to run a venture fund in the psychedelics space.     ❤️ Help us fund the future of psychedelic medicine at Empath Ventures: https://www.empath.vc  ⭐️ Become an Integration Insider and get early access to episodes: https://patreon.com/theintegrationco  🐦 brom on twitter:   https://twitter.com/therealbrom  🎇 Clips and other stuff on Instagram:   https://instagram.com/theintegrationco  ⏰ Timestamps:   0:45 - Ken & Stuart’s backgrounds   6:00 - what is it like raising money for a Psychedelic Venture Fund?   14:00 - what is Negev’s focus?    19:30 - how do you do due diligence?    23:30 - do novel psychedelics replace the classic psychedelics in the long run?    26:30 - what are the developing trends in psychedelics?    37:30 - is there too much capital in the space?

Jack Swain is the Head of Clinical Operations at Mindbloom, the world's largest telemedicine based ketamine clinic.    In this episode of The Integration Conversation, Jack talks about what it's like to be involved in a rapidly growing psychedelic startup, the differences between in-clinic and telemedicine based ketamine therapy, and how Mindbloom will scale to other psychedelic drugs like psilocybin and MDMA. ❤️ Help us fund the future of psychedelic medicine at Empath Ventures:  https://www.empath.vc  📺 Watch on YouTube:  https://youtu.be/HskAmw27a-M  ⭐️ Become an Integration Insider and get early access to episodes:  https://patreon.com/theintegrationco  🐦 brom on twitter:   https://twitter.com/therealbrom  🎇 Clips and other stuff on Instagram:   https://instagram.com/theintegrationco   disclaimer:  this is not financial advice

Paul Kohlhaas is the cofounder of Molecule ( https://molecule.to/ ) a collaborative platform where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients.  He is also the co-initiator of VitaDAO ( https://www.vitadao.com/ ), a decentralized collective funding early stage longevity research.  In this episode we discuss the exciting intersection of crypto and biotech, and how DAOs might replace some of the traditional funding mechanisms of scientific research.       ❤️ Help us fund the future of psychedelic medicine at Empath Ventures: https://www.empath.vc

Bruce Linton is a legend in the cannabis and psychedelics industries.  He was the CEO of the world's largest cannabis company (Canopy Growth), was the first investor in MindMed, and is Chairman of the Advisory Board at Red Light Holland.    Bruce joins The Integration Conversation to answer questions like:   Why did Bruce Linton sell shares in MindMed?  Why did JR leave MindMed?  What's the difference between paid promotion & pump and dumps?  Are psychedelics just cannabis 2.0?    And more!    Plus, Brom and Bruce talk about Empath Ventures.   ❤️ Help us fund the future of psychedelic medicine at Empath Ventures:  https://www.empath.vc  ⭐️ Become an Integration Insider and get early access to episodes:  https://patreon.com/theintegrationco  🐦 brom on twitter:   https://twitter.com/therealbrom  🎇 Clips and other stuff on Instagram:   https://instagram.com/theintegrationco Disclaimer / Disclosure:  This is not financial advice.  Brom owns shares in MindMed, Red Light Holland and other psychedelics stocks.